SNCA and Parkinson disease: Proteomics is capable of quantitation of high numbers of proteins from minimal sample volumes, hence this review focuses on recent proteomic studies and disease-related post-translational modifications in key proteins such as α-synuclein in PD, which may serve as biomarkers in recent times.